Association of Monocyte Chemoattractant Protein-1 (MCP-1) 2518 A/G Polymorphism with Obesity in Korean Type 2 Diabetes Mellitus
Sangshin Park,Dong-Hwa Lee,Shinyoung Lee,Hyun Jeong Jeon
DOI: https://doi.org/10.2147/dmso.s484860
2024-10-22
Diabetes Metabolic Syndrome and Obesity Targets and Therapy
Abstract:Sangshin Park, 1, &ast Dong-Hwa Lee, 2, &ast Shinyoung Lee, 1 Hyun Jeong Jeon 2 1 Department of Internal Medicine, Chungbuk National University Hospital, Cheongju, Korea; 2 Department of Internal Medicine, Chungbuk National University College of Medicine and Chungbuk National University Hospital, Cheongju, Korea &astThese authors contributed equally to this work Correspondence: Hyun Jeong Jeon, Department of Internal Medicine, Chungbuk National University College of Medicine 1 Chungbuk Na-Tional University Hospital, 776, 1Sunhwan-ro, Seowon-gu, Cheongju-si, Chungcheongbuk-do, 28644, South Korea, Tel +82-43-269-6352, Email Purpose: Monocyte chemoattractant protein-1 (MCP-1) is a member of the CC chemokine family, and the MCP-1 2518 A/G gene polymorphism is reported to be correlated with chronic inflammatory diseases, including insulin resistance and metabolic syndrome. However, few studies have investigated the association between MCP-1 gene polymorphisms and obesity in patients with type 2 diabetes mellitus (T2DM). We conducted a retrospective case-control study and evaluated the association between the MCP-1 2518 A/G polymorphism and obesity in Korean patients with T2DM. Patients and Methods: This single-center, retrospective, case-control study enrolled 526 Korean patients with T2DM. Obesity was defined using the body mass index (BMI) with a cutoff level of 25 kg/m 2 . Polymerase chain reaction-restriction fragment length polymorphism was used to analyze MCP-1 2518 A/G polymorphism; the genotypes was presented as GG, AG, or AA. We compared the MCP-1 2518 A/G polymorphism with the prevalence of diabetic complications, as well as clinical and biochemical characteristics. Results: The obese group had a higher number of females and higher C-peptide, insulin, triglycerides, aspartate transaminase (AST), and alanine transaminase (ALT) levels. The obese group also had a higher prevalence of cardiovascular disease than the non-obese group. The obese group had a higher frequency of the MCP-1 2518 AA genotype and the A allele than the non-obese group. The results of multiple logistic regression analysis showed that the non-G allele of MCP-1 was significantly associated with obesity (odds ratio (OR), 1.888; P=0.016). Conclusion: This study demonstrates that the MCP-1 2518 A/G polymorphism is associated with obesity in Korean patients with T2DM. Further studies involving various ethnic groups are required to validate our results. Keywords: obesity, MCP-1 protein, polymorphism, diabetes mellitus Obesity is increasing at an alarming rate worldwide owing to changes in lifestyle and eating habits. According to the World Health Organization, approximately 30% of the world's population was considered overweight or obese in 2020. 1 The prevalence of obesity in Korea is comparable to the global prevalence, and increased from 31.4% in 2009 to 38.3% in 2020. In addition, the prevalence of obese individuals with a body mass index (BMI) of 35kg/m2 or higher tripled to 26.3% in 2021. The prevalence of obesity also differs by sex, with 48% in the male population and 27.7% in the female population. 2 The obesity rate among patients with type 2 diabetes mellitus (T2DM) is reported to be approximately 50%. The obesity rate of patients with T2DM in Korea is 54.4%: 12.9% for class II obesity, with a BMI of 30kg/m2 or higher, and 1.9% for class III obesity, with a BMI of 35 kg/m2 or higher. 3 Obesity induces a chronic inflammatory response by increasing the production of adipokines and various inflammatory cytokines owing to the excessive accumulation of adipocytes in the body. Leptin, resistin, and adiponectin are adipokines that are secreted by adipocytes. Adiponectin is closely associated with obesity and is markedly reduced in obese patients. Adiponectin is responsible for anti-inflammatory reactions, such as reducing the expression of adhesion molecules, and plays a role in inhibiting atherosclerosis. 4 Therefore, atherosclerosis may occur more easily in obese patients with reduced adiponectin levels than in healthy individuals. Obesity in diabetes causes intravascular atherosclerosis due to reduced adiponectin and increased leptin production, which increases the incidence of chronic diabetic complications. 5 Therefore, active weight management is necessary for patients with diabetes. Monocyte chemoattractant protein-1 (MCP-1) is a CC chemokine that was discovered in 1989 and plays a pivotal role in the development of inflammation. 6 Key factors in MCP-1 production are cytokines, such as tumor necrosis factor-alpha (TNF-α) and inter-leukin (IL)-1β, which are secreted from excess -Abstract Truncated-
endocrinology & metabolism